Page last updated: 2024-10-27

fluconazole and Congenital Thrombotic Thrombocytopenic Purpura

fluconazole has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Neurologic adverse effects of triazole antifungal compounds used for the treatment of systemic and deep mycoses are relatively rare."1.62Acute fluconazole toxicity: a case presenting with protean manifestations including systemic and neurologic symptoms. ( Ergene, U; Eşkut, N; Gedizlioğlu, M; Özlü, C; Ünal, O, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Eşkut, N1
Gedizlioğlu, M1
Ünal, O1
Özlü, C1
Ergene, U1

Other Studies

1 other study available for fluconazole and Congenital Thrombotic Thrombocytopenic Purpura

ArticleYear
Acute fluconazole toxicity: a case presenting with protean manifestations including systemic and neurologic symptoms.
    Postgraduate medicine, 2021, Volume: 133, Issue:2

    Topics: Acute Kidney Injury; Antifungal Agents; Confusion; Drug-Related Side Effects and Adverse Reactions;

2021